Floatz logo

Prednisone

High Grade B-Cell Lymphoma

National Cancer Institute (NCI)Small moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
89/ 100

Competitive context

84 Active assets in the High Grade B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Isocyclophosphamide
University of California, Davis
Phase 3BB
Etoposide
University of Washington
Phase 3BB
Vincristine Sulfate
National Cancer Institute (NCI)
Phase 2/3BB
Adriamycin
National Cancer Institute (NCI)
Phase 3BB
Axicabtagene Ciloleucel
AIDS Malignancy Consortium
Phase 2BB

View all 50 →

Same molecule, other indications

Prednisone is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
74 / 100
View asset →
diffuse large B-cell lymphomaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →